Background Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a
serious threat to global efforts to combat tuberculosis. Inconsistent findings on the …

Background Although diabetes and poor glycaemic control significantly increase the risk of
tuberculosis and adversely affect tuberculosis treatment outcomes, the global burden of …

BACKGROUND: Previous evidence synthesis has suggested diabetes mellitus (DM)
worsens tuberculosis (TB) treatment outcomes. However, these reviews are limited by the …

Background Diabetes mellitus (DM) poses a significant risk for the development of active
tuberculosis (TB) and complicates its treatment. However, there is inconclusive evidence on …

La tuberculosis (TB) era la primera causa de mortalidad infecciosa mundial hasta la
pandemia de COVID-19. Afecta sobre todo a los países en vías de desarrollo (PVD) …

Tuberculosis is one of the leading causes of death worldwide, primarily affecting low-and
middle income countries and individuals with limited-resources within fractured health care …

Background: Tobacco smoking is a risk factor for tuberculosis but little is known about the
relationship between tobacco smoking and drug-resistant tuberculosis (DR-TB). We …

Background Accumulating evidence suggested that the use of metformin had more benefits
for both prevention and treatment of tuberculosis (TB) than non-metformin use in patients …

Over a quarter of the world's population is infected with Mycobacterium tuberculosis (Mtb),
the causative agent of tuberculosis (TB). Approximately 3.4% of new and 18% of recurrent …

Diabetes is a major risk factor for tuberculosis (TB). Diabetes increases the risk of the
progression from latent tuberculosis infection (LTBI) to active pulmonary TB and TB patients …